[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Uveitis Therapeutics Market Treatment (Corticosteroids, Antibiotics, Antivirals, Antifungal, Analgesics, and Others), By Disease (Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, and Pan uveitis), Regional Forecasts 2021-2027

January 2022 | 200 pages | ID: G904541E62F9EN
Bizwit Research & Consulting LLP

US$ 4,950.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Uveitis Therapeutics Market is valued approximately at USD 0.53 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 5.8% over the forecast period 2021-2027. Uveitis treatment is used to cure the middle layer of tissues in the eyewall uvea. Various type of drugs is used in the treatment of Uveitis such as cycloplegic agents, anti-inflammatory, antimicrobial drugs, immunotherapy & targeted therapies, and others are used in treatment of uveitis. The market growth is driven by the key factors such as rise in awareness among patient population adopting advanced therapeutics and increased R&D efforts for the discovery of novel medicines. For instance, EyePoint Pharmaceuticals, Inc. received FDA clearance for YUTIQ, an implant used to treat non-infectious uveitis in the posterior segment of the eye, in 2018. Furthermore, With growing cases of infectious diseases, the prevalence of uveitis with infectious etiologies is also rising. The majority of cases occur in underdeveloped nations. According to the Indian Journal of Inflammation Research, infections cause roughly half of all uveitis cases in India. Infectious etiologies are also a major cause of ocular inflammation in developing nations. However,Steep prices of medications and side effects of the medication may impede market growth over the forecast period of 2021-2027.

North America is dominating the market growth of uveitis treatment, due to the early approval of pipeline drugs as compared to other regions. The rising prevalence of uveitis and associated illnesses, the growing geriatric population, and increased investments in research and development by drug manufacturing companies for creating novel therapies such as corticosteroids are all contributing to the regional market's growth.

Major market player included in this report are:
Regeneron Pharmaceuticals, Inc
Eyepoint pharmaceuticals Inc.
Novartis AG
Bausch Health Inc.
AbbVie Inc.
Eyegate Pharmaceuticals, Inc.
Alimera Science Inc.
Santen Pharmaceuticals
Clearside Biomedical inc.
Bausch & Lomb Incorporated

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment:
Corticosteroids
Antibiotics
Antivirals
Antifungal
Analgesics
Others
By Disease:
Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.

Target Audience of the Global Uveitis Therapeutics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
  1.2.1. Uveitis Treatment Market, by Region, 2019-2027 (USD Billion)
  1.2.2. Uveitis Treatment Market, by Treatment, 2019-2027 (USD Billion)
  1.2.3. Uveitis Treatment Market, by Diseases, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

CHAPTER 2. GLOBAL UVEITIS TREATMENT MARKET DEFINITION AND SCOPE

2.1. Objective of the Study
2.2. Market Definition & Scope
  2.2.1. Scope of the Study
  2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

CHAPTER 3. GLOBAL UVEITIS TREATMENT MARKET DYNAMICS

3.1. Uveitis Treatment Market Impact Analysis (2019-2027)
  3.1.1. Market Drivers
    3.1.1.1. Rising expenditure on the research and development of new drugs and treatments
    3.1.1.2. Rising incidence of uveitis and its complications
  3.1.2. Market Restraint
    3.1.2.1. Steep prices of medications and side effects of the medication
  3.1.3. Market Opportunities
    3.1.3.1. Surge in R&D activities to develop ideal uveitis therapeutics
    3.1.3.2. Rising R&D activities for biological drugs

CHAPTER 4. GLOBAL UVEITIS TREATMENT MARKET: INDUSTRY ANALYSIS

4.1. Porter’s 5 Force Model
  4.1.1. Bargaining Power of Suppliers
  4.1.2. Bargaining Power of Buyers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
  4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
  4.2.1. Political
  4.2.2. Economic
  4.2.3. Social
  4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion

CHAPTER 5. RISK ASSESSMENT: COVID -19 IMPACT

5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID 19and Post COVID 19 market scenarios

CHAPTER 6. GLOBAL UVEITIS TREATMENT MARKET, BY TREATMENT

6.1. Market Snapshot
6.2. Global Uveitis Treatment Market by Treatment, Performance - Potential Analysis
6.3. Global Uveitis Treatment Market Estimates & Forecasts by Treatment 2018-2027 (USD Billion)
6.4. Uveitis Treatment Market, Sub Segment Analysis
  6.4.1. Corticosteroids
  6.4.2. Antibiotics
  6.4.3. Antivirals
  6.4.4. Antifungal
  6.4.5. Analgesics
  6.4.6. Others

CHAPTER 7. GLOBAL UVEITIS TREATMENT MARKET, BY DISEASES

7.1. Market Snapshot
7.2. Global Uveitis Treatment Market by Diseases, Performance - Potential Analysis
7.3. Global Uveitis Treatment Market Estimates & Forecasts by Diseases 2018-2027 (USD Billion)
7.4. Uveitis Treatment Market , Sub Segment Analysis
  7.4.1. Anterior Uveitis
  7.4.2. Posterior Uveitis
  7.4.3. Intermediate Uveitis
  7.4.4. Panuveitis

CHAPTER 8. GLOBAL UVEITIS TREATMENT MARKET, REGIONAL ANALYSIS

8.1. Uveitis Treatment Market , Regional Market Snapshot
8.2. North America Uveitis Treatment Market
  8.2.1. U.S. Uveitis Treatment Market
    8.2.1.1. Treatment breakdown estimates & forecasts, 2018-2027
    8.2.1.2. Diseases breakdown estimates & forecasts, 2018-2027
  8.2.2. Canada Uveitis Treatment Market
8.3. Europe Uveitis Treatment Market Snapshot
  8.3.1. U.K. Uveitis Treatment Market
  8.3.2. Germany Uveitis Treatment Market
  8.3.3. France Uveitis Treatment Market
  8.3.4. Spain Uveitis Treatment Market
  8.3.5. Italy Uveitis Treatment Market
  8.3.6. Rest of Europe Uveitis Treatment Market
8.4. Asia-Pacific Uveitis Treatment Market Snapshot
  8.4.1. China Uveitis Treatment Market
  8.4.2. India Uveitis Treatment Market
  8.4.3. Japan Uveitis Treatment Market
  8.4.4. Australia Uveitis Treatment Market
  8.4.5. South Korea Uveitis Treatment Market
  8.4.6. Rest of Asia Pacific Uveitis Treatment Market
8.5. Latin America Uveitis Treatment Market Snapshot
  8.5.1. Brazil Uveitis Treatment Market
  8.5.2. Mexico Uveitis Treatment Market
8.6. Rest of The World Uveitis Treatment Market

CHAPTER 9. COMPETITIVE INTELLIGENCE

9.1. Top Market Strategies
9.2. Company Profiles
  9.2.1. Regeneron Pharmaceuticals, Inc
    9.2.1.1. Key Information
    9.2.1.2. Overview
    9.2.1.3. Financial (Subject to Data Availability)
    9.2.1.4. Product Summary
    9.2.1.5. Recent Developments
  9.2.2. Eyepoint pharmaceuticals Inc.
  9.2.3. Novartis AG
  9.2.4. Bausch Health Inc.
  9.2.5. AbbVie Inc.
  9.2.6. Eyegate Pharmaceuticals, Inc.
  9.2.7. Alimera Science Inc.
  9.2.8. Santen Pharmaceuticals
  9.2.9. Clearside Biomedical inc.
  9.2.10. Bausch & Lomb Incorporated

CHAPTER 10. RESEARCH PROCESS

10.1. Research Process
  10.1.1. Data Mining
  10.1.2. Analysis
  10.1.3. Market Estimation
  10.1.4. Validation
  10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Uveitis Treatment Market, report scope
TABLE 2. Global Uveitis Treatment Market estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 3. Global Uveitis Treatment Market estimates & forecasts by Treatment 2018-2027 (USD Billion)
TABLE 4. Global Uveitis Treatment Market estimates & forecasts by Diseases 2018-2027 (USD Billion)
TABLE 5. Global Uveitis Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 6. Global Uveitis Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Uveitis Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Uveitis Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Uveitis Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Uveitis Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Uveitis Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Uveitis Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Uveitis Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Uveitis Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Uveitis Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. Global Uveitis Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. Global Uveitis Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 18. Global Uveitis Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Global Uveitis Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Global Uveitis Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 21. U.S. Uveitis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. U.S. Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 23. U.S. Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. Canada Uveitis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 25. Canada Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 26. Canada Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. UK Uveitis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 28. UK Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 29. UK Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. Germany Uveitis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 31. Germany Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 32. Germany Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. France Uveitis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 34. France Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 35. France Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. Spain Uveitis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 37. Spain Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 38. Spain Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. Italy Uveitis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 40. Italy Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 41. Italy Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. ROE Uveitis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 43. ROE Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 44. ROE Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. China Uveitis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 46. China Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 47. China Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. India Uveitis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 49. India Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 50. India Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. Japan Uveitis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 52. Japan Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 53. Japan Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. Australia Uveitis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 55. Australia Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 56. Australia Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 57. South Korea Uveitis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 58. South Korea Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 59. South KoreaUveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 60. ROPAC Uveitis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 61. ROPAC Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 62. ROPAC Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 63. Brazil Uveitis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 64. Brazil Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 65. Brazil Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 66. Mexico Uveitis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 67. Mexico Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 68. Mexico Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 69. ROLA Uveitis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 70. ROLA Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 71. ROLA Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 72. ROW Uveitis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 73. ROW Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 74. ROW Uveitis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 75. List of secondary sources used in the study of Global Uveitis Treatment Market.
TABLE 76. List of primary sources used in the study of Global Uveitis Treatment Market.
TABLE 77. Years considered for the study.
TABLE 78. Exchange rates considered.

LIST OF FIGURES

FIG 1. Global Uveitis Treatment Market, research methodology
FIG 2. Global Uveitis Treatment Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Uveitis Treatment Market, key trends 2020
FIG 5. Global Uveitis Treatment Market, growth prospects 2021-2027
FIG 6. Global Uveitis Treatment Market, porters 5 force model
FIG 7. Global Uveitis Treatment Market, pest analysis
FIG 8. Global Uveitis Treatment Market, value chain analysis
FIG 9. Global Uveitis Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Uveitis Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Uveitis Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Uveitis Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Uveitis Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Uveitis Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 15. Global Uveitis Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 16. Global Uveitis Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 17. Global Uveitis Treatment Market, regional snapshot 2018 & 2027
FIG 18. North America Uveitis Treatment Market 2018 & 2027 (USD Billion)
FIG 19. Europe Uveitis Treatment Market 2018 & 2027 (USD Billion)
FIG 20. Asia-Pacific Uveitis Treatment Market 2018 & 2027 (USD Billion)
FIG 21. Latin America Uveitis Treatment Market 2018 & 2027 (USD Billion)
FIG 22. Global Uveitis Treatment Market, company market share analysis (2020)


More Publications